Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2013 (2013), Article ID 896709, 6 pages
http://dx.doi.org/10.1155/2013/896709
Research Article

The Extracts of Some Marine Invertebrates and Algae Collected off the Coast Waters of Vietnam Induce the Inhibitory Effects on the Activator Protein-1 Transcriptional Activity in JB6 Cl41 Cells

1Laboratory of Marine Natural Products Chemistry, G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far-East Branch of the Russian Academy of Sciences, Prospect 100-let Vladivostoku 159, Vladivostok 690022, Russia
2Institute of Marine Biochemistry, Vietnam Academy of Science and Technology, Hanoi, Vietnam

Received 29 June 2012; Revised 6 December 2012; Accepted 19 December 2012

Academic Editor: Ana B. Martin-Diana

Copyright © 2013 S. N. Fedorov et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Eferl and E. F. Wagner, “AP-1: a double-edged sword in tumorigenesis,” Nature Reviews Cancer, vol. 3, no. 11, pp. 859–868, 2003. View at Google Scholar · View at Scopus
  2. M. R. Young, J. J. Li, M. Rincon, and R. A. Flavell, “Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 17, pp. 9827–9832, 1999. View at Google Scholar
  3. E. Shaulian and M. Karin, “AP-1 as a regulator of cell life and death,” Nature Cell Biology, vol. 4, no. 5, pp. E131–E136, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. L. R. Bernstein and N. H. Colburn, “AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells,” Science, vol. 244, no. 4904, pp. 566–569, 1989. View at Google Scholar · View at Scopus
  5. E. Tulchinsky, “Fos family members: regulation, structure and role in oncogenic transformation,” Histology and Histopathology, vol. 15, no. 3, pp. 921–928, 2000. View at Google Scholar
  6. W. Jochum, E. Passegué, and E. F. Wagner, “AP-1 in mouse development and tumorigenesis,” Oncogene, vol. 20, no. 19, pp. 2401–2412, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Angel and M. Karin, “The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation,” Biochimica et Biophysica Acta, vol. 1072, no. 2-3, pp. 129–157, 1991. View at Google Scholar
  8. Z. Q. Wang, A. E. Grigoriadis, U. Mohle-Steinlein, and E. F. Wagner, “A novel target cell for c-fos-induced oncogenesis: development of chondrogenic tumours in embryonic stem cell chimeras,” EMBO Journal, vol. 10, no. 9, pp. 2437–2450, 1991. View at Google Scholar · View at Scopus
  9. Z. Dong, R. G. Watts, Y. Sun, S. N. Zhan, and N. H. Colburn, “Progressive elevation of AP-1 activity during preneoplastic-to-neoplastic progression as modeled in mouse JB6 cell variants,” International Journal of Oncology, vol. 7, no. 2, pp. 359–364, 1995. View at Google Scholar · View at Scopus
  10. Z. G. Dong, M. J. Birrer, R. G. Watts, and L. M. Matrisian, “Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 2, pp. 609–613, 1994. View at Google Scholar
  11. J. M. Gee, J. F. Robertson, I. O. Ellis, and R. I. Nicholson, “Impact of activation of MAP kinase family members on endocrine and survival in clinical breast cancer,” European Journal of Cancer, vol. 36, supplement 4, article 105, 2000. View at Google Scholar
  12. B. Neyns, E. Teugels, C. Bourgain, M. Birrer, and J. de Greve, “Alteration of Jun proto-oncogene status by plasmid transfection affects growth of human ovarian cancer cells,” International Journal of Cancer, vol. 82, no. 5, pp. 687–693, 1999. View at Google Scholar
  13. B. K. Prusty and B. C. Das, “Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin,” International Journal of Cancer, vol. 113, no. 6, pp. 951–960, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Wang, M. Birkenbach, and J. Hart, “Expression of Jun family members in human colorectal adenocarcinoma,” Carcinogenesis, vol. 21, no. 7, pp. 1313–1317, 2000. View at Google Scholar · View at Scopus
  15. S. Linardopoulos, E. Papadakis, D. Delakas, V. Theodosiou, A. Cranidis, and D. A. Spandidos, “Human lung and bladder carcinoma tumors as compared to their adjacent normal tissue have elevated AP-1 activity associated with the retinoblastoma gene promoter,” Anticancer Research, vol. 13, no. 1, pp. 257–262, 1993. View at Google Scholar · View at Scopus
  16. R. Chiu, P. Angel, and M. Karin, “Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun,” Cell, vol. 59, no. 6, pp. 979–986, 1989. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Passegué, W. Jochum, M. Schorpp-Kistner, U. Möhle-Steinlein, and E. F. Wagner, “Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking JunB expression in the myeloid lineage,” Cell, vol. 104, no. 1, pp. 21–32, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Le-Niculescu, E. Bonfoco, Y. Kasuya, F. X. Claret, D. R. Green, and M. Karin, “Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death,” Molecular and Cellular Biology, vol. 19, no. 1, pp. 751–763, 1999. View at Google Scholar · View at Scopus
  19. T. Kondo, T. Matsuda, T. Kitano et al., “Role of c-jun expression increased by heat shock- and ceramide-activated caspase-3 in HL-60 cell apoptosis. Possible involvement of ceramide in heat shock-induced apoptosis,” The Journal of Biological Chemistry, vol. 275, no. 11, pp. 7668–7676, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Kasibhatla, T. Brunner, L. Genestier, F. Echeverri, A. Mahboubi, and D. R. Green, “DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1,” Molecular Cell, vol. 1, no. 4, pp. 543–551, 1998. View at Google Scholar · View at Scopus
  21. S. K. Manna, N. K. Sah, and B. B. Aggarwal, “Protein tyrosine kinase p56(lck) is required for ceramide-induced but not tumor necrosis factor-induced activation of NF-κB, AP-1, JNK, and apoptosis,” The Journal of Biological Chemistry, vol. 275, no. 18, pp. 13297–13306, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Leppä, M. Eriksson, R. Saffrich, W. Ansorge, and D. Bohmann, “Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells,” Molecular and Cellular Biology, vol. 21, no. 13, pp. 4369–4378, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Gopalakrishnan and A. N. Kong, “Anticarcinogenesis by dietary phytochemicals: cytoprotection by Nrf2 in normal cells and cytotoxicity by modulation of transcription factors NF-κB and AP-1 in abnormal cancer cells,” Food and Chemical Toxicology, vol. 46, no. 4, pp. 1257–1270, 2008. View at Google Scholar
  24. E. F. Wagner and R. Eferl, “Fos/AP-1 proteins in bone and the immune system,” Immunological Reviews, vol. 208, pp. 126–140, 2005. View at Google Scholar · View at Scopus
  25. Y. Yan, G.-X. Zhang, M. S. Williams et al., “TCR stimulation upregulates MS4a4B expression through induction of AP-1 transcription factor during T cell activation,” Molecular Immunology, vol. 52, no. 2, pp. 71–78, 2012. View at Publisher · View at Google Scholar
  26. G. Raivich and A. Behrens, “Role of the AP-1 transcription factor c-Jun in developing, adult and injured brain,” Progress in Neurobiology, vol. 78, no. 6, pp. 347–363, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. S. Kindy, J. P. Carney, R. J. Dempsey, and J. M. Carney, “Ischemic induction of protooncogene expression in gerbil brain,” Journal of Molecular Neuroscience, vol. 2, no. 4, pp. 217–228, 1991. View at Google Scholar · View at Scopus
  28. R. Zenz and E. F. Wagner, “Jun signalling in the epidermis: from developmental defects to psoriasis and skin tumors,” International Journal of Biochemistry and Cell Biology, vol. 38, no. 7, pp. 1043–1049, 2006. View at Google Scholar
  29. K. W. Kim, J. Im, J. H. Jeon, H.-G. Lee, C.-H. Yun, and S. H. Han, “Staphylococcus aureus induces IL-1β expression through the activation of MAP kinases and AP-1, CRE and NF-κB transcription factors in the bovine mammary gland epithelial cells,” Comparative Immunology, Microbiology and Infectious Diseases, vol. 34, no. 4, pp. 347–354, 2011. View at Google Scholar
  30. V. D. Leaner, H. Donninger, and M. J. Birrer, “Transcription factors as targets for cancer therapy: AP-1 a potential therapeutic target,” Current Cancer Therapy Reviews, vol. 3, no. 1, pp. 1–6, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Yu, V. Hebbar, D. W. Kim, S. Mandlekar, J. M. Pezzuto, and A. N. T. Kong, “Resveratrol inhibits phorbol ester and UV-induced activator protein 1 activation by interfering with mitogen-activated protein kinase pathways,” Molecular Pharmacology, vol. 60, no. 1, pp. 217–224, 2001. View at Google Scholar · View at Scopus
  32. S. N. Fedorov, S. A. Dyshlovoy, M. M Monastyrnaya et al., “The anticancer effects of actinoporin RTX-A from the sea anemone Heteractis crispa (=Radianthus macrodactylus),” Toxicon, vol. 55, no. 4, pp. 811–817, 2010. View at Google Scholar · View at Scopus
  33. S. N. Fedorov, L. K. Shubina, A. A. Kicha et al., “Proapoptotic and anticarcinogenic activities of leviusculoside G from the starfish Henricia leviuscula and probable molecular mechanism,” Natural Product Communications, vol. 3, no. 10, pp. 1575–1580, 2008. View at Google Scholar · View at Scopus
  34. A. Berry, M. Goodwin, C. L. Moran, and T. C. Chambers, “AP-1 activation and altered AP-1 composition in association with increased phosphorylation and expression of specific Jun and Fos family proteins induced by vinblastine in KB-3 cells,” Biochemical Pharmacology, vol. 62, no. 5, pp. 581–591, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Fan, M. E. Goodwin, M. J. Birrer, and T. C. Chambers, “The c-Jun NH2-terminal protein kinase/AP-1 pathway is required for efficient apoptosis induced by vinblastine,” Cancer Research, vol. 61, no. 11, pp. 4450–4458, 2001. View at Google Scholar · View at Scopus
  36. A. Gopalakrishnan, C. J. Xu, S. S. Nair, C. Chen, V. Hebbar, and A. N. T. Kong, “Modulation of activator protein-1 (AP-1) and MAPK pathway by flavonoids in human prostate cancer PC3 cells,” Archives of Pharmacal Research, vol. 29, no. 8, pp. 633–644, 2006. View at Google Scholar · View at Scopus
  37. L. K. Shubina, S. N. Fedorov, O. S. Radchenko et al., “Desmethylubiquinone Q2 from the far-Eastern ascidian Aplidium glabrum: structure and synthesis,” Tetrahedron Letters, vol. 46, no. 4, pp. 559–562, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. S. N. Fedorov, O. S. Radchenko, L. K. Shubina et al., “Evaluation of cancer-preventive activity and structure-activity relationships of 3-demethylubiquinone Q2, isolated from the ascidian Aplidium glabrum, and its synthetic analogs,” Pharmaceutical Research, vol. 23, no. 1, pp. 70–81, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. S. N. Fedorov, O. S. Radchenko, L. K. Shubina et al., “Anticancer activity of 3-demethylubiquinone Q2. In vivo experiments and probable mechanism of action,” Anticancer Research, vol. 28, no. 2A, pp. 927–932, 2008. View at Google Scholar · View at Scopus
  40. C. Huang, W. Y. Ma, M. R. Young, N. Colburn, and Z. Dong, “Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 1, pp. 156–161, 1998. View at Google Scholar
  41. J. A. Baltrop, T. C. Owen, A. H. Cory, and J. G. Cory, “5-(3-carboxymethoxyphenyl)-2-(4, 5-dimethylthiazolyl)-3-(4-sulfophenyl)tetrazolium, inner salt (MTS) and related analogs of 3-(4, 5-dimethylthiazolyl)-2, 5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans As cell-viability indicators,” Bioorganic & Medicinal Chemistry Letters, vol. 1, no. 11, pp. 611–614, 1991. View at Google Scholar
  42. S. N. Fedorov, L. K. Shubina, A. S. Kuzmich, and S. G. Polonik, “Antileukemic properties and structure-activity relationships of O- and S-glycosylated derivatives of juglone and related 1, 4-naphthoquinones,” Open Glycoscience, vol. 4, pp. 1–5, 2011. View at Google Scholar
  43. S. A. Dyshlovoy, S. N. Fedorov, A. I. Kalinovsky et al., “Mycalamide a shows cytotoxic properties and prevents EGF-induced neoplastic transformation through inhibition of nuclear factors,” Marine Drugs, vol. 10, no. 6, pp. 1212–1224, 2012. View at Google Scholar
  44. S. N. Fedorov, S. A. Dyshlovoy, L. K. Shubina, A. G. Guzii, A. S. Kuzmich, and T. N. Makarieva, “C11 cyclopentenone from the ascidian diplosoma sp. prevents epidermal growth factor-induced transformation of JB6 cells,” Drugs and Therapy Studies, vol. 2, no. 1, article e4, 2012. View at Publisher · View at Google Scholar